Browsing by Author "Arsovic, Nenad (17033449500)"
Now showing 1 - 20 of 20
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Acute onset of tinnitus in patients with sudden deafness(2021) ;Cvorovic, Ljiljana (16229375800) ;Arsovic, Nenad (17033449500) ;Radivojevic, Nemanja (57216412671) ;Soldatovic, Ivan (35389846900)Hegemann, Stefan (6602895241)Objective: We made hypotheses that tinnitus will appear more likely in patients with sudden deafness with superior hearing in unaffected ear or with more severe acute hearing loss. Methods: A retrospective cohort study was performed. Five hundred forty-one patients were identified with idiopathic sudden sensorineural hearing loss (ISSHL) from January 1995 to August 2006. The exclusion criteria for this study were as follows: bilateral sudden hearing loss and Meniere disease, previous tinnitus or bilateral tinnitus at initial evaluation, and onset of hearing loss less than 7 days. The cohort enrolled 454 patients. The enrolled patients were classified into two groups: patient with acute onset tinnitus in the affected ear and patients without tinnitus at initial visit. Main outcome measures were patient age, the presence or absence of vertigo and tinnitus, audiometric patterns, the severity of hearing loss, and hearing in the unaffected ear. Results: Better contralateral hearing (n = 220 versus n = 72, P < 0.001) and younger age (48 versus 55 years, P < 0.001) were independently associated with the acute onset of tinnitus in patients with ISSHL. The degree of asymmetry between the ears did not differ significantly between patients with and without tinnitus. The sex, presence of vertigo, shape of audiogram, and severity of hearing loss were not correlated with tinnitus occurrence. Conclusions: Tinnitus triggered by ISSHL was more frequent in patients with better contralateral hearing and of a younger age, irrespective of the severity of hearing loss on the affected side or the asymmetry between the ears. © 2021 Noise & Health | Published by Wolters Kluwer - Medknow. - Some of the metrics are blocked by yourconsent settings
Publication Clinical Characteristics and Treatment Experiences of Pediatric Acute Mastoiditis and Its Complications at the University Tertiary Care Center in the 10-Year Prevaccinal Period(2023) ;Cvorovic, Ljiljana (16229375800) ;Dudvarski, Zoran (6504165244) ;Relic, Nenad (57209459323) ;Radivojevic, Nemanja (57216412671) ;Soldatovic, Ivan (35389846900)Arsovic, Nenad (17033449500)Introduction: We aim to provide an overview of the clinical characteristics and treatment of pediatric acute mastoiditis (AM) and its complications in the prevaccinal pneumococcal period. Materials and methods: Retrospective case series. An analysis of pediatric patients with AM treated at a university tertiary care center from 2008 to 2018 was performed. Results: The research included 121 children, and 27.3% of them had some form of complication. The mean age at presentation of AM was 3.7 years (range = 0–18 years). The most common extracranial complication of AM was a subperiosteal abscess (n = 25, 75.8%) and the most common intracranial complication was meningoencephalitis (n = 2, 6%). The most common pathogen isolated in the complicated AM was Streptococcus pneumoniae (n = 17, 51.5%). A total of 60% of patients reported antibiotic use before hospital admission, mostly third-generation cephalosporins (37.5%). There was a statistically significant difference between age group and occurrence of complications (P =.001). Females had complications more frequently than males (P =.035). There were no statistically significant differences in levels of inflammatory parameters (C-reactive protein and leukocyte count) between patients with or without complications (P =.373 and P =.124; respectively). All patients with complications of AM were surgically treated. Mortality was 0% and all children completely recovered. Conclusion: Extracranial and intracranial complications of AM required surgical treatment and extended antibiotic therapy. Inflammation parameters did not have a predictive role in identifying children with complications of AM. Further investigations will determine whether the introduction of the mandatory pneumococcal vaccine in our country has led to a reduction in the incidence of AM and its complications. © The Author(s) 2023. - Some of the metrics are blocked by yourconsent settings
Publication Clinical outcomes and quality of life in patients with nasal polyposis after functional endoscopic sinus surgery(2014) ;Djukic, Vojko (6701658274) ;Dudvarski, Zoran (6504165244) ;Arsovic, Nenad (17033449500) ;Dimitrijevic, Milovan (25642808400)Janosevic, Ljiljana (6603730103)The majority of studies have shown that the use of functional endoscopic sinus surgery (FESS) leads to symptomatic improvement in 73–98.4 % of patients with chronic rhinosinusitis and nasal polyposis (NP). The aim of the study is to evaluate clinical outcomes and quality of life (QoL) in patients with NP after FESS. The prospective study included 85 consecutive adult patients (≥18 years) with NP who were operated on using FESS after failure of the medicamentous treatment and in certain cases of surgical treatment. QoL was assessed by Short Form-36 Health Survey (SF-36) questionnaire, and the symptom intensity was presented using visual analogue scale (VAS). The objective finding was presented as endoscopic and computerized tomography (CT) score. The intensity of each symptom, the values of symptom scores (major, minor and total), the values of dimension scales and summary scales of the QoL, as well as the values of endoscopic score through three periods of time (pre-surgery, 6 and 12 months after the surgery) were analyzed. Following the FESS, mean intensity values of all individual symptoms and symptom scores were significantly lower and the values of all dimension scales and summary scales of QoL were significantly higher (p < 0.05). There was no statistically significant difference in symptom intensity and QoL after 6 and 12 months of surgical treatment (p > 0.05). Endoscopic score was on average significantly lower after 6 and 12 months of FESS (p < 0.05), but the mean score value after 12 months of operation was significantly higher in relation to that after 6 months of surgery (p < 0.05). Nevertheless, the recurrence of NP was observed in 28 patients (32.9 %) in the follow-up period. In conclusion, FESS in NP patients results in significant improvement of symptom intensity, QoL and endoscopic score. While the intensity of symptoms and QoL showed a tendency to maintain between 6 and 12 months after surgery, endoscopic score showed a tendency of exacerbation in the same period. © 2014, Springer-Verlag Berlin Heidelberg. - Some of the metrics are blocked by yourconsent settings
Publication Indirect laryngeal surgery of vocal fold polyps: a dying or evolving art?; [Chirurgia laringea indiretta dei polipi delle corde vocali: un’arte in via di estinzione o in evoluzione?](2023) ;Cukic, Ognjen (57204627351) ;Radaljac, Dejan (57397504500) ;Arsovic, Nenad (17033449500) ;Jovanovic, Milan (57209619634)Milutinovic, Zoran (7003458956)Objective. Vocal fold polyps (VFPs) are the most common benign laryngeal lesions that require surgery and are routinely managed by microlaryngoscopy (MLS) under general an-aesthesia. Prior to introduction of MLS, VFPs were removed using indirect laryngoscopic surgery (ILS) in local anaesthesia, a procedure that required substantial surgical skill to operate with an unmagnified mirror view of the larynx. With the adoption of wireless en-doscopy equipment and personal computers, we tried to simplify this technique so that it can be easily performed in the office. This study aimed to assess the effectiveness of ILS by comparing voice outcomes with MLS. Materials and methods. ILS and MLS were performed in six patients each. Treatment outcomes were measured using a voice self-assessment and objective acoustic analysis. The total cost of both procedures was calculated. Results. Both techniques allowed successful removal of VFPs in all patients, without sig-nificant intergroup differences in voice outcomes. The cost of ILS was significantly lower. Conclusions. Despite the pilot nature of the study and the small sample size, our data in-dicate the potential value of this technique which, considering its simplicity and economic value could be used as an alternative to MLS in carefully selected patients. © Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale. - Some of the metrics are blocked by yourconsent settings
Publication Influence of cardiovascular risk factors on cochlear dysfunction(2020) ;Radivojevic, Nemanja (57216412671) ;Arsovic, Nenad (17033449500) ;Dudvarski, Zoran (6504165244) ;Nesic, Vladimir (6701399959) ;Cvorovic, Ljiljana (16229375800) ;Babac, Snezana (19638244900)Radivojevic, Aleksandra (57221256147)Background: Cochlear dysfunction can arise not only from various factors such as ear diseases but also from systemic disorders of the body. The occurrence of otologic symptoms such as hearing loss, dizziness, and tinnitus can be due to cardiovascular disorders. Therefore, current understandings in the field of the diagnosis and therapy of cardiovascular diseases (CVDs) should include, among others, evidence of otologic disorders. Objective: The aim of this study is to determine the association between risk factors for CVD and cochlear dysfunction. Methods: The cross-sectional study included 128 participants with major CVD risk factors who underwent auditory function examination (pure tone audiometry). Results: There were 52 women (40.6%) and 76 men (59.4%) in total. The mean age of the participants was 58 years (a range of 28-83 years). The mean age among participants with hearing loss was 60 (±10.88), whereas the mean age among participants that had normal hearing thresholds was 54 (±12.18). Sensorineural hearing loss (SNHL) was measured in 59% of participants, of most frequent mild degree hearing loss. The prevalence of SNHL was higher in participants with arterial hypertension (P < 0.001, OR = 5.881, 95% CI 2.694-12.837) and the most common among them was moderate degree hearing impairment (38%). There is also a statistically significant association of SNHL with dyslipidemia and elevated body mass index (P < 0.001, [OR]: 4.118, 95% [CI]: 1.873-9.053 and P< 0.001, [OR]: 1.517, 95% [CI]: 1.237-1.859 ) with moderate and profound hearing loss. Conclusion: Based on the data obtained, it seems that the presence of major cardiovascular risk factors was a significant predictor for cochlear dysfunction. © 2020 Wolters Kluwer Medknow Publications. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Meta-signature guided investigation of miRNA candidates as potential biomarkers of oral cancer(2023) ;Stojkovic, Goran (59498807300) ;Jovanovic, Ivan (57193205472) ;Dimitrijevic, Milovan (25642808400) ;Jovanovic, Jasmina (56140174500) ;Tomanovic, Nada (22941937200) ;Stankovic, Aleksandra (7006485474) ;Arsovic, Nenad (17033449500) ;Boricic, Ivan (6603959716)Zeljic, Katarina (37035590000)Objectives: This study aimed to experimentally validate dysregulated expression of miRNA candidates selected through updated meta-analysis of most commonly deregulated miRNAs in oral cancer and to explore their diagnostic and prognostic potential. Materials and methods: Five miRNAs (miR-31-3p, miR-135b-5p, miR-18a-5p, miR-30a-5p and miR-139-5p) from updated meta-signature were selected for validation by qRT-PCR method in 35 oral cancer clinical specimens and adjacent non-cancerous tissue. Results: Updated meta-analysis has identified 13 most commonly deregulated miRNAs in oral cancer. Seven miRNAs were consistently up-regulated (miR-21-5p, miR-31-3p, miR-135b-5p, miR-31-5p, miR-424-5p, miR-18a-5p and miR-21-3p), while five were down-regulated (miR-139-5p, miR-30a-3p, miR-375-3p, miR-376c-3p and miR-30a-5p). Increased expression of miR-31-3p and miR-135b-5p, and decreased expression of miR-139-5p and miR-30a-5p were confirmed in oral cancer compared to adjacent non-cancerous tissue. A three miRNAs combination (miR-31-3p, miR-139-5p and miR-30a-5p) gave the most promising diagnostic potential for discriminating oral cancer from non-cancerous tissue (AUC: 0.780 [95% CI: 0.673–0.886], p < 0.0005, sensitivity 94.3%, specificity 51.4%). High expression of miR-135b-5p, miR-18a-5p and miR-30a-5p was associated with poor survival (p = 0.003, p = 0.048, p = 0.016 respectively). Conclusion: miR-31-3p, miR-139-5p and miR-30a-5p panel was confirmed as a potential diagnostic biomarker when distinguishing oral cancer from non-cancerous tissue. miR-135b-5p, miR-18a-5p and miR-30a-5p might serve as potential biomarkers of poor survival of oral cancer patients. © 2022 Wiley Periodicals LLC. - Some of the metrics are blocked by yourconsent settings
Publication Meta-signature guided investigation of miRNA candidates as potential biomarkers of oral cancer(2023) ;Stojkovic, Goran (59498807300) ;Jovanovic, Ivan (57193205472) ;Dimitrijevic, Milovan (25642808400) ;Jovanovic, Jasmina (56140174500) ;Tomanovic, Nada (22941937200) ;Stankovic, Aleksandra (7006485474) ;Arsovic, Nenad (17033449500) ;Boricic, Ivan (6603959716)Zeljic, Katarina (37035590000)Objectives: This study aimed to experimentally validate dysregulated expression of miRNA candidates selected through updated meta-analysis of most commonly deregulated miRNAs in oral cancer and to explore their diagnostic and prognostic potential. Materials and methods: Five miRNAs (miR-31-3p, miR-135b-5p, miR-18a-5p, miR-30a-5p and miR-139-5p) from updated meta-signature were selected for validation by qRT-PCR method in 35 oral cancer clinical specimens and adjacent non-cancerous tissue. Results: Updated meta-analysis has identified 13 most commonly deregulated miRNAs in oral cancer. Seven miRNAs were consistently up-regulated (miR-21-5p, miR-31-3p, miR-135b-5p, miR-31-5p, miR-424-5p, miR-18a-5p and miR-21-3p), while five were down-regulated (miR-139-5p, miR-30a-3p, miR-375-3p, miR-376c-3p and miR-30a-5p). Increased expression of miR-31-3p and miR-135b-5p, and decreased expression of miR-139-5p and miR-30a-5p were confirmed in oral cancer compared to adjacent non-cancerous tissue. A three miRNAs combination (miR-31-3p, miR-139-5p and miR-30a-5p) gave the most promising diagnostic potential for discriminating oral cancer from non-cancerous tissue (AUC: 0.780 [95% CI: 0.673–0.886], p < 0.0005, sensitivity 94.3%, specificity 51.4%). High expression of miR-135b-5p, miR-18a-5p and miR-30a-5p was associated with poor survival (p = 0.003, p = 0.048, p = 0.016 respectively). Conclusion: miR-31-3p, miR-139-5p and miR-30a-5p panel was confirmed as a potential diagnostic biomarker when distinguishing oral cancer from non-cancerous tissue. miR-135b-5p, miR-18a-5p and miR-30a-5p might serve as potential biomarkers of poor survival of oral cancer patients. © 2022 Wiley Periodicals LLC. - Some of the metrics are blocked by yourconsent settings
Publication Otitis media and facial paralysis as presenting symptoms of a primary middle ear sarcoidosis(2013) ;Arsovic, Nenad (17033449500) ;Babic, Borivoj (25121401500) ;Dimitrijevic, Milovan (25642808400) ;Bukurov, Bojana (55605047500)Vucinic, Violeta (13410407800)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Otitis media and facial paralysis as presenting symptoms of a primary middle ear sarcoidosis(2013) ;Arsovic, Nenad (17033449500) ;Babic, Borivoj (25121401500) ;Dimitrijevic, Milovan (25642808400) ;Bukurov, Bojana (55605047500)Vucinic, Violeta (13410407800)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Prognostic value of serum 25-hydroxyvitamin D levels and malnutrition status on postoperative complications in patients following laryngectomy with neck dissection(2025) ;Radivojevic, Nemanja (57216412671) ;Grujicic, Sandra Sipetic (56676073300) ;Suljagic, Vesna (6506075339) ;Stojkovic, Stefan (58448712900) ;Arsovic, Konstantin (58782102600) ;Jakovljevic, Sasa (57455265100) ;Bukurov, Bojana (55605047500)Arsovic, Nenad (17033449500)Background: Postoperative complications (PCs) following total laryngectomy remain a significant challenge, with recent investigations directed toward the impact of nutrition status and vitamin D deficiency. Objectives: To elucidate the association between preoperative vitamin D level status, malnutrition risk score, and surgical and survival outcomes in patients with advanced laryngeal cancer following total laryngectomy. Study design: Prospective cohort study. Methods: Sixty-four patients with advanced laryngeal carcinoma treated with total laryngectomy were included in the study. Serum levels of 25(OH) D3 were measured employing a commercial chemiluminescent immunoassay kit, while nutrition status was evaluated using the nutrition risk index (NRI) and Malnutrition universal screening tool (MUST). Results: The mean serum 25(OH) D level was 37.1 ± 19.4 nmol/L (range 11.0-100.6 nmol/L), with 47% of patients exhibiting vitamin D deficiency and 31% displaying insufficiency. Medium/high MUST score had 53% of patients, and moderate/severe NRI was verified in 48% of patients. Univariate logistic regression analysis identified MUST score, GPS score, neutrophil-to-lymphocyte ratio, and circulating 25(OH) D levels as predictive for the occurrence of PCs. In multivariate analysis, MUST score and circulating 25(OH) D levels remained significantly associated with PCs. Patients with high nutrition risk had significantly lower two-year OS rates compared to the medium and low nutrition risk groups, respectively (30% vs. 62% and 83%, p = 0.010). Conclusion: Early identification of malnourished or patients with vitamin D deficiency and those who would benefit from specific nutritional support could be beneficial for minimizing the risk of development of surgical complications and help improve our clinical outcomes. © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. - Some of the metrics are blocked by yourconsent settings
Publication Psychometric characteristics of the chronic Otitis media questionnaire 12 (COMQ - 12): Stability of factor structure and replicability shown by the Serbian version(2017) ;Bukurov, Bojana (55605047500) ;Arsovic, Nenad (17033449500) ;Grujicic, Sandra Sipetic (56676073300) ;Haggard, Mark (7007159749) ;Spencer, Helen (7201921823)Marinkovic, Jelena Eric (7004611210)Background: Recently, demand for and supply of short-form patient-reported outcome measures (PROMs) have risen throughout the world healthcare. Our contribution to meeting that demand has been translating and culturally adapting the Chronic Otitis Media Questionnaire-12 (COMQ-12) for adults into Serbian and enhancing its psychometric base on the relatively large Serbian COM caseload. Chronic otitis media can seriously affect quality of life progressively and in long-term, and it remains the major source of hearing problems in the developing world. Methods: The translated questionnaire was given twice to 60 adult patients with chronic otitis media of three types (inactive, active mucosal and active squamous disease) and to 60 healthy volunteers. Both patients and volunteers also filled the generic Short-Form 36 questionnaire (SF-36). Conventional statistical procedures were used in strategically driven development of scoring. Additionally, item responses were scaled by linear mapping against the provisional total score. Generalizability, detailed factor interpretation and supportability of scores were criteria, for the best compromise factor solution. Results: Test-retest reliability was very high (0.924 to 0.989, depending on score). The a priori content dimensions of the questionnaire were strongly supported by 3-factor exploratory and confirmatory factor analyses for content validity, separating (i) ear symptoms from (ii) hearing problems, from (iii) daily activity restriction plus healthcare uptake. The 3-factor structure was furthermore highly stable on replication. The very large effect sizes when contrasting patients with healthy volunteers, and active with inactive disease established construct validity for the total score. A strong association with disease activity and a moderate one with generic health-related quality of life (HRQoL), the SF-36, supported construct validity for two of three factors extracted (ear symptoms, and impact on daily activities plus healthcare uptake). Conclusions: Given the minimal psychometric work to date on COMQ-12, this interim sample with 120 data points adds materially to knowledge of its reliability, several forms of validity and the feasibility of profile sub-scores to supplement total scores. The good psychometric properties shown for COMQ-12 justify both its routine clinical use and acquisition of the necessarily larger sample for generality, score optimisation and the evaluation of responsiveness. © 2017 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss(2013) ;Cvorovic, Ljiljana (16229375800) ;Jovanovic, Milan B. (57209619634) ;Milutinovic, Zoran (7003458956) ;Arsovic, Nenad (17033449500)Djeric, Dragoslava (7006706299)OBJECTIVE: To compare the effects of hyperbaric oxygen (HBO) and intratympanic (IT) steroid injection on hearing after the failure of primary treatment in patients with idiopathic sudden sensorineural hearing loss (ISSHL). STUDY DESIGN: A prospective randomized trial. SETTING: Tertiary referral center. PATIENTS: Fifty patients with failure of primary therapy for ISSHL. INTERVENTION(S): After primary treatment with systemic steroids and failure of therapy, defined as less than 10-dB hearing gain, 50 patients were enrolled in the study and received either hyperbaric oxygen or intratympanic steroid treatment. The patients were not matched and not similar. MAIN OUTCOME MEASURE(S): Hearing gain at 0.25, 0.5, 1, 2, and 4 kHz after treatment. RESULTS: There were significant differences between hearing thresholds at all frequencies before and after the HBO treatment. Similarly, there were significant differences between hearing thresholds at most frequencies (except 2 kHz) before and after the treatment in the IT group. The subgroups of patients with pure tone average less than 81 dB and were younger than 60 years had better response to HBO treatment than those with profound deafness and in the elderly. CONCLUSION: HBO and IT steroid therapy could be successfully used as salvage therapies in patients with sudden deafness. Further study is needed to demonstrate superiority of one of the treatments. © 2013, Otology &Neurotology, Inc. - Some of the metrics are blocked by yourconsent settings
Publication Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss(2013) ;Cvorovic, Ljiljana (16229375800) ;Jovanovic, Milan B. (57209619634) ;Milutinovic, Zoran (7003458956) ;Arsovic, Nenad (17033449500)Djeric, Dragoslava (7006706299)OBJECTIVE: To compare the effects of hyperbaric oxygen (HBO) and intratympanic (IT) steroid injection on hearing after the failure of primary treatment in patients with idiopathic sudden sensorineural hearing loss (ISSHL). STUDY DESIGN: A prospective randomized trial. SETTING: Tertiary referral center. PATIENTS: Fifty patients with failure of primary therapy for ISSHL. INTERVENTION(S): After primary treatment with systemic steroids and failure of therapy, defined as less than 10-dB hearing gain, 50 patients were enrolled in the study and received either hyperbaric oxygen or intratympanic steroid treatment. The patients were not matched and not similar. MAIN OUTCOME MEASURE(S): Hearing gain at 0.25, 0.5, 1, 2, and 4 kHz after treatment. RESULTS: There were significant differences between hearing thresholds at all frequencies before and after the HBO treatment. Similarly, there were significant differences between hearing thresholds at most frequencies (except 2 kHz) before and after the treatment in the IT group. The subgroups of patients with pure tone average less than 81 dB and were younger than 60 years had better response to HBO treatment than those with profound deafness and in the elderly. CONCLUSION: HBO and IT steroid therapy could be successfully used as salvage therapies in patients with sudden deafness. Further study is needed to demonstrate superiority of one of the treatments. © 2013, Otology &Neurotology, Inc. - Some of the metrics are blocked by yourconsent settings
Publication Secondary Ewing's sarcoma of the temporo-occipital region developed 12-years after medulloblastoma treatment(2022) ;Dudvarski, Zoran (6504165244) ;Arsovic, Nenad (17033449500) ;Sopta, Jelena (24328547800) ;Gacic-Manojlovic, Emilija (57456047300) ;Radivojevic, Nemanja (57216412671)Jakovljevic, Sasa (57455265100)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Sudden sensorineural hearing loss as first presenting symptom of unifocal langerhans cell histiocytosis in the temporal bone(2013) ;Arsovic, Nenad (17033449500) ;Tomanovic, Nada (22941937200)Bukurov, Bojana (55605047500)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Sudden sensorineural hearing loss as first presenting symptom of unifocal langerhans cell histiocytosis in the temporal bone(2013) ;Arsovic, Nenad (17033449500) ;Tomanovic, Nada (22941937200)Bukurov, Bojana (55605047500)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Syringocystadenoma Papilliferum in the External Ear Canal(2022) ;Jakovljevic, Sasa (57455265100) ;Arsovic, Nenad (17033449500) ;Boricic, Novica (56515320500) ;Laketic, Darko (25936376800)Dudvarski, Zoran (6504165244)Out of all benign tumors of the ceruminous glands, syringocystadenoma papilliferum is the rarest and represents only 2% of cases. It is an extremely rare benign tumor that originates from modified apocrine sweat glands. The aim of this paper was to present, according to our findings, the 18th case of syringocystadenoma papilliferum in the external auditory canal, with a detailed review of its clinical, radiological and histomorphological characteristics. A 59-year-old man reported to our clinic due to a 5 × 5 mm papillomatous growth at the entrance to the right external auditory canal. Histopathology indicated, after an excisional biopsy, that it was a syringocystadenoma papilliferum. The resection lines were free of tumor tissue, and the patient has no signs of tumor recurrence. Although rare, it should be considered as a differential diagnosis of lesions in this region. Complete excision is mandatory in order to avoid recurrence and potential malignant alteration. © 2022 Academy of Medical Sciences of I.R. Iran. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication The Impact of Primary Tumor Volume on Survival of Patients with Non-Surgically Treated Advanced-Stage Hypopharyngeal Cancer– Retrospective Study and Literature Overview(2025) ;Jakovljevic, Sasa (57455265100) ;Djordjevic, Vladimir (57189371857) ;Tomanovic, Nada (22941937200) ;Arsovic, Nenad (17033449500) ;Dudvarski, Zoran (6504165244) ;Ursulovic, Tamara (57203867714) ;Laketic, Darko (25936376800) ;Jovanovic, Katarina (59330549500) ;Arsovic, Konstantin (58782102600)Radivojevic, Nemanja (57216412671)To determine the prognostic value of tumor volume in predicting the survival in patients with stage III–IV of hypopharyngeal carcinoma. We studied 71 patients with advanced stage of hypopharyngeal carcinoma. The volume of primary tumor was calculated by approximation of the ellipsoid volume. Correlation between carcinoma volume and demographic, clinical and carcinoma characteristics has shown that male patients and patients consuming alcohol had greater tumor volumes. The median of overall survival was at 12 months (95% CI: 9.25–14.75); the median of progression-free survival was at 9 months (95% CI: 6.6–11.3). ROC Curve Analysis of carcinoma volumes in outcome prediction shows that the cutoff of 14.69 had the sensitivity of 61% and specifics of 89%. Based on significant independent impact of tumor volume on survival, it is important to include this parameter among possible new treatment protocols. © Association of Otolaryngologists of India 2024. - Some of the metrics are blocked by yourconsent settings
Publication Why do treatment failure and recurrences of benign paroxysmal positional vertigo occur?(2014) ;Babac, Snezana (19638244900) ;Djeric, Dragoslava (7006706299) ;Petrovic-Lazic, Mirjana (26641927500) ;Arsovic, Nenad (17033449500)Mikic, Aleksandar (57214281171)OBJECTIVE: To investigate the potential risk factors associated to the treatment failure and recurrence of benign paroxysmal positional vertigo (BPPV). STUDY DESIGN: Prospective cohort study. SETTING: Tertiary referral center. PATIENTS: Four hundred patients with benign paroxysmal positional vertigo, 119 men and 281 women, aged 27 to 88 years. INTERVENTION: Patients were treated once a week, with only one, appropriate, depending on the affected canal, repositioning maneuver (modified Epley, Semont, barbecue/inverted Gufoni, Kim). The control Dix-Hallpike test and the roll test were performed on 7 days. MAIN OUTCOME MEASURES: The treatment outcome and recurrence were evaluated with regard to sex, age, duration of symptoms, etiologic factors, migraines, osteoporosis, vascular risk factors, endocrine diseases, localization of otoconia, and simultaneous involvement of multiple canals. RESULTS: The results indicate that treatment was negatively affected by patients' age, osteoporosis, and head trauma, without them causing recurrent symptoms. The highest number of uncured patients was observed in the 73- to 88-year-old age group (14.8%). The application of more than one maneuver was necessary in 27.5% of cases with primary BPPV and 88.9% with secondary BPPV. The highest treatment success was achieved in the group with BPPV of the posterior semicircular canal (F = 3.668, p = 0.026). The recurrence rate was 15.5%. CONCLUSION: Potential risk factors associated to the treatment failure were as follows: the age older than 50, secondary BPPV, head trauma, the occurrence of osteoporosis, and localization of otoconia in the anterior semicircular canal. The analyzed factors did not have impact on the recurrence. © 2014, Otology & Neurotology, Inc. - Some of the metrics are blocked by yourconsent settings
Publication Why do treatment failure and recurrences of benign paroxysmal positional vertigo occur?(2014) ;Babac, Snezana (19638244900) ;Djeric, Dragoslava (7006706299) ;Petrovic-Lazic, Mirjana (26641927500) ;Arsovic, Nenad (17033449500)Mikic, Aleksandar (57214281171)OBJECTIVE: To investigate the potential risk factors associated to the treatment failure and recurrence of benign paroxysmal positional vertigo (BPPV). STUDY DESIGN: Prospective cohort study. SETTING: Tertiary referral center. PATIENTS: Four hundred patients with benign paroxysmal positional vertigo, 119 men and 281 women, aged 27 to 88 years. INTERVENTION: Patients were treated once a week, with only one, appropriate, depending on the affected canal, repositioning maneuver (modified Epley, Semont, barbecue/inverted Gufoni, Kim). The control Dix-Hallpike test and the roll test were performed on 7 days. MAIN OUTCOME MEASURES: The treatment outcome and recurrence were evaluated with regard to sex, age, duration of symptoms, etiologic factors, migraines, osteoporosis, vascular risk factors, endocrine diseases, localization of otoconia, and simultaneous involvement of multiple canals. RESULTS: The results indicate that treatment was negatively affected by patients' age, osteoporosis, and head trauma, without them causing recurrent symptoms. The highest number of uncured patients was observed in the 73- to 88-year-old age group (14.8%). The application of more than one maneuver was necessary in 27.5% of cases with primary BPPV and 88.9% with secondary BPPV. The highest treatment success was achieved in the group with BPPV of the posterior semicircular canal (F = 3.668, p = 0.026). The recurrence rate was 15.5%. CONCLUSION: Potential risk factors associated to the treatment failure were as follows: the age older than 50, secondary BPPV, head trauma, the occurrence of osteoporosis, and localization of otoconia in the anterior semicircular canal. The analyzed factors did not have impact on the recurrence. © 2014, Otology & Neurotology, Inc.
